Journals / Marmara Medical Journal / 2016 / Cilt: 29 - Sayı: 2

Latest updates on chronic delta hepatitis

Pages
50–54
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In contrast, the controlof HBV infecion does not seem to change the natural history ofHDV related disease.Keywords: Delta hepatitis, Treatment, Prognosis

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The hepatitis D virus was shown for the first time in 1977 byRizzetto and friends.
📊
Key Findings & Data:The HDV genome and the cloning ofsequence were made in 1986.
💡
Conclusion & Impact:In contrast, the controlof HBV infecion does not seem to change the natural history ofHDV related disease.Keywords: Delta hepatitis, Treatment, Prognosis
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hepatit D · Tedavi · Prognoz

Abstract

The hepatitis D virus was shown for the first time in 1977 byRizzetto and friends. The HDV genome and the cloning ofsequence were made in 1986. HDV is the first animal virus withcircular RNA genome which is seen only in plant viruses. HDVis an RNA virus with the known smallest viral genome in animalviruses. It is classified as Deltavirus genius depending on the typeof virus by ICTV in 1996. HDV is classified as the sole example ofdelta virus in this genus.Chronic delta hepatitis is the least common form of chronicviral hepatitis due to hepatotropic viruses. In contrast, the virusis highly pathogenic and can cause serious consequences. Today,prevalance of delta hepatitis has been shown to decrease. However,the delta hepatitis continues to be an important health problem insome parts of the world. In our country, especially in Eastern andSoutheastern Anatolia, hepatitis D is a serious and important healthproblem and still maintains its importance as a health problem. InTurkey, still there is a significant number of patients with HDVinfection despite a documented decrease in HDV infection.The recommended treatment for chronic HDV infection in thecurrent guidelines is the treatment with peginterferon alfa givenonce a week for 48 weeks. Treatment is indicated for patients whohas compensated disease with active infection. In patients withadvanced form of disease, the expected benefits of the peginterferonmust be well balanced against the potential side effects and lowresponse rate. An oral antiviral can be recommended in patientswho has high levels of serum HBV DNA. In contrast, the controlof HBV infecion does not seem to change the natural history ofHDV related disease.Keywords: Delta hepatitis, Treatment, Prognosis

Özet

The hepatitis D virus was shown for the first time in 1977 byRizzetto and friends. The HDV genome and the cloning ofsequence were made in 1986. HDV is the first animal virus withcircular RNA genome which is seen only in plant viruses. HDVis an RNA virus with the known smallest viral genome in animalviruses. It is classified as Deltavirus genius depending on the typeof virus by ICTV in 1996. HDV is classified as the sole example ofdelta virus in this genus.Chronic delta hepatitis is the least common form of chronicviral hepatitis due to hepatotropic viruses. In contrast, the virusis highly pathogenic and can cause serious consequences. Today,prevalance of delta hepatitis has been shown to decrease. However,the delta hepatitis continues to be an important health problem insome parts of the world. In our country, especially in Eastern andSoutheastern Anatolia, hepatitis D is a serious and important healthproblem and still maintains its importance as a health problem. InTurkey, still there is a significant number of patients with HDVinfection despite a documented decrease in HDV infection.The recommended treatment for chronic HDV infection in thecurrent guidelines is the treatment with peginterferon alfa givenonce a week for 48 weeks. Treatment is indicated for patients whohas compensated disease with active infection. In patients withadvanced form of disease, the expected benefits of the peginterferonmust be well balanced against the potential side effects and lowresponse rate. An oral antiviral can be recommended in patientswho has high levels of serum HBV DNA. In contrast, the controlof HBV infecion does not seem to change the natural history ofHDV related disease.Keywords: Delta hepatitis, Treatment, Prognosis

🔖

Cite This Article

YALÇIN, K., TUNCEL, E. T., GÜNDÜZ, F. (2016). Latest updates on chronic delta hepatitis. Marmara Medical Journal, Cilt: 29 - Sayı: 2, 50–54. https://ajindex.com/articles/284302

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Rizzetto M. Critical care options. In: Afdhal NH, Zeuzem S editors. Clinical Care Options, Hepatitis, Practice, Hepatitis Delta virus. Last Reviewed: 6/23/14 (What’s New). Taylor JM. Replication of the hepatitis delta virus RNA genome. Adv Virus Res 2009;74:103-21.
  2. Greco-Stewart VS, Schissel E, Pelchat M. The hepatitis delta virus RNA genome interacts with the human RNA polymerases I and III. Virology 2009;386:12-5. World Health Organization. Hepatitis B fact sheet 204 (updated July 2013). Available at: http://www.who.int/ mediacentre/factsheets/fs204/en/index.html. Accessed June 2014.
  3. Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet 2011;378:73-85.
  4. Rizzetto M, Ciancio A. Epidemiology of hepatitis D. Semin Liver Dis 2012;32:211-9. Farci P. Delta hepatitis: an update. J Hepatol 2003;39(suppl S212-S219. Genné D, Rossi I. Hepatitis delta in Switzerland: a silent epidemic. Swiss Med Wkly 2011 Mar 18. Stroffolini T, Almasio PL, Sagnelli E, Mele A, Gaeta GB. Italian Hospitals’ Collaborating Group. Evolving clinical landscape of chronic hepatitis B: a multicenter Italian study. J Med Virol 2009;81:1999-2006.
  5. Değertekin H, Yalcin K, Yakut M, Yurdaydin C. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis. Liver Int 2008;28:494-8.
  6. Bahcecioglu IH, Aygun C, Gozel N, Poyrazoglu OK, Bulut Y Yalniz M. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider. J Viral Hepat 2011;18:518-24.
  7. Degertekin H, Yalcin K, Yakut M. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: An analysis of clinical studies. Turk J Gastroenterol 17:25-34.
  8. Yalçın K, Yalçın S, Büyükbayram H, et al. Kronik HDV infeksiyonlu hastalarda serum HBV DNA, HDV RNA düzeyleri ve histolojik bulguların hastalığın klinik evreleriyle ilişkisi: prospektif klinik çalışma. 25. Ulusal Gastroenteroloji Haftası, 2008.
  9. Yalçın K, Değertekin H. Etiology and clinical aspects of liver cirrhosis in Diyarbakır. National congress of Gastroenterology, Turkey, 2002.
  10. Bonino F, Caporaso N, Dentico P, et al. Familiar clustering and spreading of hepatitis delta virus infection. J Hepatol 1:221-6.
  11. Wu JC, Chen CM, Sheen IJ, et al. Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome. Hepatology 1995;226:1656-60.
  12. Rosenblum L, Darrow W, Witte J, et al. Sexual practices in the